Pre-approval of Prescription Drug Advertisements in the Shadow of Central Hudson

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Ginn, Clifford M.	en_US
dc.date.accessioned	2012-06-15T20:29:42Z
dc.date.issued	2003	en_US
dc.identifier.citation	Pre-approval of Prescription Drug Advertisements in the Shadow of Central Hudson (2003 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889479
dc.description.abstract	The article examines the effects of prescription drug advertising on patients and physicians, and explains how a requirement of pre-approval by the FDA for prescription drug advertisements could eliminate many of the problems such advertisements create, without limiting the benefits of advertising or violating the First Amendment of the U.S. Constitution.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Administrative law	en
dc.subject	preapproval	en
dc.subject	prescription drug	en
dc.subject	advertising	en
dc.subject	advertisement	en
dc.subject	doctor	en
dc.subject	physician	en
dc.subject	patient	en
dc.subject	first amendment	en
dc.subject	commercial speech	en
dc.title	Pre-approval of Prescription Drug Advertisements in the Shadow of Central Hudson	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-15T20:29:42Z

Files	Size	Format	View
Pre-approval_of_Prescription_Drug_Ads2.pdf	235.8Kb	PDF	View/Open
Pre-approval_of_Prescription_Drug_Ads2.rtf	159.0Kb	RTF file	View/Open
Pre-approval_of_Prescription_Drug_Ads2.html	176.6Kb	HTML	View/Open